Summary

Canada and MENA DNA and RNA Extraction Kits Market Research Report Forecast to 2032

Market Overview
DNA extraction and RNA extraction are both procedures for isolating and purifying nucleic acids from cells. Superior quality DNA and RNA are used in biotechnology, molecular biology, epidemiology, and genomic demonstrations.
The Canada and MENA DNA and RNA extraction kits market is predicted to expand due to increasing prevalence of cancer and increasing investments in R&D., However, lack of skilled personnel is limiting market expansion. The introduction of new products on the other hand, boosts the market's attractiveness.
Increased expenditures in research and development efforts in several areas, including molecular diagnostics for various chronic and infectious illnesses, are likely to drive the growth of the DNA/RNA extraction kit market over the forecast period. According to Statistique Canada, over a five-year period, the Canadian business sector's total in-house R&D expenditures have showed a constant increase trend, growing from $18.7 billion in 2016 to $27.3 billion in 2021. This amounts to a about 7.9% compound annual growth rate. R&D is critical to encouraging innovation and technical improvement, which drives economic growth and Canadian competitiveness in a global economy. In fields such as healthcare, R&D may lead to the development of new or enhanced products and procedures that improve our quality of life.
Market Segmentation
Based on Product, Canada and MENA DNA and RNA Extraction Kits Market has been segmented into cell free DNA, sequence specific DNA, sequence specific RNA, total RNA, and others.
Based on Application, the Canada and MENA DNA and RNA Extraction Kits market has been segmented into disease diagnosis, drug discovery, and Others.
Based on end user, the Canada and MENA DNA and RNA Extraction Kits market has been segmented into hospitals & clinics, diagnostic laboratories, academic and research institutions, and others.
Based on region, the Canada and MENA DNA and RNA extraction kits market is segmented into the Canada and MENA.
Major Players
F. Hoffmann-La Roche Ltd (Roche), QIAGEN, Beckman Coulter Inc. (Beckman), Agilent Technologies Inc (Agilent), Promega Corporation, Thermo Fisher Scientific, Inc. (Thermo Fisher), Bio-Rad Laboratories, Inc., Becton, Dickinson and Company (BD), Biotium,

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 12
2 MARKET INTRODUCTION 14
2.1 DEFINITION 14
2.2 SCOPE OF THE STUDY 14
2.3 RESEARCH OBJECTIVE 14
2.4 MARKET STRUCTURE 15
3 MARKET DYNAMICS 17
3.1 INTRODUCTION 17
3.2 DRIVERS 18
3.2.1 Growing R&D and demand for DNA and RNA Extraction Kits 18
3.2.2 increasing prevelance of cancer 18
3.3 RESTRAINT 19
3.3.1 lack of skilled personnel 19
3.4 OPPORTUNITIES 20
3.4.1 Technological advancement and launches of new products 20
3.5 FUTURE TRENDS IN DNA/RNA EXTRACTION KIT MARKET 21
4 MARKET FACTOR ANALYSIS 22
4.1 VALUE CHAIN ANALYSIS 22
4.1.1 R&D 23
4.1.2 Manufacturing 23
4.1.3 Distribution And Sales 24
4.1.4 Post-Sales Monitoring 24
4.2 PORTER’S FIVE FORCES MODEL 25
4.2.1 Threat of New Entrants 25
4.2.2 Bargaining Power of Suppliers 26
4.2.3 Threat of Substitutes 26
4.2.4 Bargaining Power of Buyers 26
4.2.5 Intensity of Rivalry 26
4.3 IMPACT OF COVID-19 ON THE CANADA AND MENA DNA AND RNA EXTRACTION KITS
MARKET 27
4.3.1 impact on supply chain 27
4.3.2 IMPACT ON DEMAND AND SUPPLY 27
4.4 TOTAL NUMBER OF DNA AND RNA EXTRACTION TESTS PERFORMED IN CANADA AND
MENA (2022) 28
5 CANADA & MENA DNA & RNA EXTRACTION KITS MARKET, BY PRODUCT 30
5.1 OVERVIEW 30
5.2 CELL FREE DNA 33
5.3 SEQUENCE SPECIFIC DNA 33
5.4 SEQUENCE SPECIFIC RNA 33
5.5 TOTAL RNA 34
5.6 TOTAL NUCLEIC ACID 34
5.7 OTHERS 34
6 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION 35
6.1 OVERVIEW 35
6.2 DISEASE DIAGNOSIS 37
6.2.1 Hemato-Oncology 38
6.2.2 Infectious Diseases 38
6.2.3 Thrombophilia 38
6.2.4 Neurological Disease 39
6.2.5 Cardiovascular Disease 39
6.2.6 Others 39
6.3 DRUG DISCOVERY 40
6.4 OTHERS 40
7 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, BY END USER 41
7.1 OVERVIEW 41
7.2 HOSPITALS & CLINICS 43
7.3 DIAGNOSTIC LABORATORIES 43
7.4 ACADEMIC AND RESEARCH INSTITUTIONS 44
7.5 OTHERS 44
8 CANADA & MENA DNA & RNA EXTRACTION KITS MARKET, BY REGION 45
8.1 OVERVIEW 45
8.2 CANADA 45
8.3 MENA 49
8.3.1 UAE 53
8.3.2 Saudi Arabia 55
8.3.3 Kuwait 57
8.3.4 Iran 59
8.3.5 Qatar 61
8.3.6 Bahrain 63
8.3.7 Egypt 65
8.3.8 Morocco 67
8.3.9 Algeria 69
8.3.10 Jordan 71
8.3.11 Syria 73
8.3.12 Lebanon 75
8.3.13 Iraq 77
8.3.14 Rest of MENA 79
9 COMPETITIVE LANDSCAPE 82
9.1 INTRODUCTION 82
9.2 MARKET SHARE ANALYSIS, 2022 82
9.3 COMPETITOR DASHBOARD 83
9.4 PUBLIC PLAYERS STOCK SUMMARY 84
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 84
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 85
9.6.1 product launch 85
9.6.2 Acquisition 85
10 COMPANY PROFILES 86
10.1 F. HOFFMANN-LA ROCHE LTD 86
10.1.1 COMPANY OVERVIEW 86
10.1.2 FINANCIAL OVERVIEW 87
10.1.3 PRODUCTS OFFERED 87
10.1.4 KEY DEVELOPMENTS 87
10.1.5 SWOT ANALYSIS 88
10.1.6 KEY STRATEGIES 88
10.2 MERCK KGAA 89
10.2.1 COMPANY OVERVIEW 89
10.2.2 FINANCIAL OVERVIEW 90
10.2.3 Products OFFERed 90
10.2.4 KEY DEVELOPMENTS 91
10.2.5 SWOT ANALYSIS 91
10.2.6 KEY STRATEGIES 91

10.3 QIAGEN 92
10.3.1 COMPANY OVERVIEW 92
10.3.2 FINANCIAL OVERVIEW 93
10.3.3 Products OFFERed 94
10.3.4 KEY DEVELOPMENTS 94
10.3.5 SWOT ANALYSIS 95
10.3.6 KEY STRATEGIES 95
10.4 BECKMAN COULTER INC 96
10.4.1 COMPANY OVERVIEW 96
10.4.2 FINANCIAL OVERVIEW 96
10.4.3 PRODUCTS OFFERED 97
10.4.4 KEY DEVELOPMENTS 97
10.4.5 KEY STRATEGIES 97
10.5 AGILENT TECHNOLOGIES, INC 98
10.5.1 COMPANY OVERVIEW 98
10.5.2 FINANCIAL OVERVIEW 99
10.5.3 PRODUCTS OFFERED 99
10.5.4 KEY DEVELOPMENTS 100
10.5.5 SWOT ANALYSIS 100
10.5.6 KEY STRATEGIES 100
10.6 PROMEGA CORPORATION 101
10.6.1 COMPANY OVERVIEW 101
10.6.2 FINANCIAL OVERVIEW 102
10.6.3 PRODUCTS OFFERED 102
10.6.4 KEY DEVELOPMENTS 102
10.6.5 KEY STRATEGIES 102
10.7 THERMO FISHER SCIENTIFIC, INC. 103
10.7.1 COMPANY OVERVIEW 103
10.7.2 FINANCIAL OVERVIEW 104
10.7.3 Products OFFERed 104
10.7.4 KEY DEVELOPMENTS 106
10.7.5 SWOT ANALYSIS 106
10.7.6 Key Strategy 107

10.8 BIO-RAD LABORATORIES, INC. 108
10.8.1 COMPANY OVERVIEW 108
10.8.2 FINANCIAL OVERVIEW 109
10.8.3 Products OFFERed 110
10.8.4 KEY DEVELOPMENTS 110
10.8.5 Key Strategy 110
10.9 BECTON, DICKINSON AND COMPANY 111
10.9.1 COMPANY OVERVIEW 111
10.9.2 FINANCIAL OVERVIEW 112
10.9.3 PRODUCTS OFFERED 113
10.9.4 Key developments 113
10.9.5 KEY STRATEGIES 113
10.10 BIOTIUM 114
10.10.1 COMPANY OVERVIEW 114
10.10.2 FINANCIAL OVERVIEW 114
10.10.3 PRODUCTS OFFERED 115
10.10.4 KEY DEVELOPMENTS 115
10.10.5 KEY STRATEGIES 115
11 DATA CITATIONS 116

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES
TABLE 1 TOTAL NUMBER OF DNA AND RNA EXTRACTION TESTS PERFORMED IN CANADA AND MENA (2022) 28
TABLE 2 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 32
TABLE 3 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR CELL FREE DNA, BY REGION, 2019–2032 (USD MILLION) 33
TABLE 4 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR SEQUENCE SPECIFIC DNA, BY REGION, 2019–2032
(USD MILLION) 33
TABLE 5 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR SEQUENCE SPECIFIC RNA, BY REGION, 2019–2032
(USD MILLION) 33
TABLE 6 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR TOTAL RNA, BY REGION, 2019–2032 (USD MILLION) 34
TABLE 7 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR TOTAL NUCLEIC ACID, BY REGION, 2019–2032
(USD MILLION) 34
TABLE 8 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 34
TABLE 9 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 37
TABLE 10 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY REGION, 2019–2032
(USD MILLION) 37
TABLE 11 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE, 2019–2032
(USD MILLION) 37
TABLE 12 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR HEMATO-ONCOLOGY, BY REGION, 2019–2032
(USD MILLION) 38
TABLE 13 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR INFECTIOUS DISEASES, BY REGION, 2019–2032
(USD MILLION) 38
TABLE 14 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR THROMBOPHILIA, BY REGION, 2019–2032
(USD MILLION) 38
TABLE 15 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR NEUROLOGICAL DISEASE, BY REGION, 2019–2032
(USD MILLION) 39
TABLE 16 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR CARDIOVASCULAR DISEASE, BY REGION, 2019–2032
(USD MILLION) 39
TABLE 17 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 39
TABLE 18 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR DRUG DISCOVERY, BY REGION, 2019–2032
(USD MILLION) 40
TABLE 19 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 40
TABLE 20 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 43
TABLE 21 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019–2032
(USD MILLION) 43
TABLE 22 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION,
2019–2032 (USD MILLION) 43
TABLE 23 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR ACADEMIC AND RESEARCH INSTITUTIONS,
BY REGION, 2019–2032 (USD MILLION) 44
TABLE 24 CANADA AND MENA DNA AND RNA EXTRACTION KITS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 44
TABLE 25 CANADA DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 47
TABLE 26 CANADA DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 48
TABLE 27 CANADA DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 48
TABLE 28 CANADA DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 48
TABLE 29 MENA DNA AND RNA EXTRACTION KITS MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 51
TABLE 30 MENA DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 52
TABLE 31 MENA DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 52
TABLE 32 MENA DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 52
TABLE 33 MENA DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 53
TABLE 34 UAE DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 53
TABLE 35 UAE DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 53
TABLE 36 UAE DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 54
TABLE 37 UAE DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 54
TABLE 38 SAUDI ARABIA DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 55
TABLE 39 SAUDI ARABIA DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 55
TABLE 40 SAUDI ARABIA DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 56
TABLE 41 SAUDI ARABIA DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 56
TABLE 42 KUWAIT DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 57
TABLE 43 KUWAIT DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 57
TABLE 44 KUWAIT DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 58
TABLE 45 KUWAIT DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 58
TABLE 46 IRAN DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 59
TABLE 47 IRAN DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 59
TABLE 48 IRAN DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 60
TABLE 49 IRAN DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 60
TABLE 50 QATAR DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 61
TABLE 51 QATAR DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 61
TABLE 52 QATAR DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 62
TABLE 53 QATAR DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 62
TABLE 54 BAHRAIN DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 63
TABLE 55 BAHRAIN DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 63
TABLE 56 BAHRAIN DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 64
TABLE 57 BAHRAIN DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 64
TABLE 58 EGYPT DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 65
TABLE 59 EGYPT DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 65
TABLE 60 EGYPT DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 66
TABLE 61 EGYPT DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 66
TABLE 62 MOROCCO DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 67
TABLE 63 MOROCCO DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 67
TABLE 64 MOROCCO DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 68
TABLE 65 MOROCCO DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 68
TABLE 66 ALGERIA DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 69
TABLE 67 ALGERIA DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 69
TABLE 68 ALGERIA DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 70
TABLE 69 ALGERIA DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 70
TABLE 70 JORDAN DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 71
TABLE 71 JORDAN DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 71
TABLE 72 JORDAN DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 72
TABLE 73 JORDAN DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 72
TABLE 74 SYRIA DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 73
TABLE 75 SYRIA DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 73
TABLE 76 SYRIA DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 74
TABLE 77 SYRIA DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 74
TABLE 78 LEBANON DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 75
TABLE 79 LEBANON DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 75
TABLE 80 LEBANON DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 76
TABLE 81 LEBANON DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 76
TABLE 82 IRAQ DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 77
TABLE 83 IRAQ DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 77
TABLE 84 IRAQ DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 78
TABLE 85 IRAQ DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 78
TABLE 86 REST OF MENA DNA AND RNA EXTRACTION KITS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 79
TABLE 87 REST OF MENA DNA AND RNA EXTRACTION KITS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 79
TABLE 88 REST OF MENA DNA AND RNA EXTRACTION KITS MARKET, FOR DISEASE DIAGNOSIS, BY TYPE 2019–2032 (USD MILLION) 80
TABLE 89 REST OF MENA DNA AND RNA EXTRACTION KITS MARKET, BY END USER, 2019–2032 (USD MILLION) 80
TABLE 90 PUBLIC PLAYERS STOCK SUMMARY 84
TABLE 91 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 84
TABLE 92 PRODUCT LAUNCH 85
TABLE 93 ACQUISITION 85
TABLE 94 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 87
TABLE 95 MERCK KGAA: PRODUCTS OFFERED 90
TABLE 96 QIAGEN: PRODUCTS OFFERED 94
TABLE 97 BECKMAN COULTER INC: PRODUCTS OFFERED 97
TABLE 98 BECKMAN COULTER INC: KEY DEVELOPMENTS 97
TABLE 99 AGILENT TECHNOLOGIES, INC: PRODUCTS OFFERED 99
TABLE 100 PROMEGA CORPORATION: PRODCUTS OFFERED 102
TABLE 101 THERMO FISHER SCIENTIFIC, INC.: PRODCUTS OFFERED 104
TABLE 102 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 110
TABLE 103 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 113
TABLE 104 BIOTIUM: PRODUCTS OFFERED 115
TABLE 105 BIOTIUM :KEY DEVELOPMENTS 115